Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis

Laryngoscope

Volumn 119, Issue 5, 2009, Pages 864-867

  Bomeli, Steven R ^a   Schaitkin, Barry ^a   Carrau, Ricardo L ^a   Walvekar, Rohan R ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Minimally invasive; Radioiodine; Salivary glands; Sialadenitis; Sialendoscopy; Thyroid

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HUMAN; MEDICAL RECORD REVIEW; PAROTID GLAND; PRIORITY JOURNAL; RADIATION INJURY; SALIVARY DUCT OBSTRUCTION; SIALENDOSCOPY; SIALOADENITIS; SIALOLITHIASIS; SUBMANDIBULAR GLAND; TREATMENT DURATION; TREATMENT FAILURE; ENDOSCOPY; METHODOLOGY; MIDDLE AGED; RADIATION EXPOSURE; RADIOTHERAPY; RETROSPECTIVE STUDY; SALIVARY GLAND; THYROID TUMOR; TREATMENT OUTCOME;

ADULT; AGED; ENDOSCOPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY; RETROSPECTIVE STUDIES; SALIVARY GLANDS; SIALADENITIS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 66349100474     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20140     Document Type: Article

References (18)

1. Allweiss P., Braunstein GD, Katz A., Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med 1984; 25:755-758.
2. Laupa MS, Toth BB, Keene HJ, Sellin RV. Effect of radioactive iodine therapy on salivary flow rates and oral Streptococcus mutans prevalence in patients with thyroid cancer. Oral Surg Oral Med Oral Pathol 1993; 75:312-317.
3. Caglar M., Tuncel M., Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med 2002; 27:767-771.
4. Edmonds CJ, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59:45-51.
5. DiRusso G., Kern KA. Comparative analysis of complications from I-131 radioablation for well-differentiated thyroid cancer. Surgery 1994; 116:1024-1030.
6. Kim JW, Han GS, Lee SH, Lee DY, Kim YM. Sialoendoscopic treatment for radioiodine induced sialadenitis. Laryngoscope 2007; 117:133-136.
7. Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid 2003; 13:265-271.
8. Nahlieli O., Nazarian Y. Sialadenitis following radioiodine therapy-a new diagnostic and treatment modality. Oral Dis 2006; 12:476-479.
9. Marchal F., Dulguerov P. Sialolithiasis management: the state of the art. Arch Otolaryngol Head Neck Surg 2003; 129:951-956.
10. Walvekar RR, Razfar A., Carrau RL, Schaitkin B. Sialendoscopy and associated complications: a preliminary experience. Laryngoscope 2008; 118:776-779.
11. Konigsberger R., Feyh J., Goetz A., Schilling V., Kastenbauer E. Endoscopic controlled laser lithotripsy in the treatment of sialolithiasis [in German]. Laryngorhinootologie 1990; 69:322-323.
12. Gundlach P., Scherer H., Hopf J., et al. Endoscopic-controlled laser lithotripsy of salivary calculi. In vitro studies and initial clinical use [in German]. HNO 1990; 38:247-250.
13. Freitas JE, Gross MD, Ripley S., Shapiro B. Radionuclide diagnosis and therapy of thyroid cancer: current status report. Semin Nucl Med 1985; 15:106-131.
14. Newkirk KA, Ringel MD, Wartofsky L., Burman KD. The role of radioactive iodine in salivary gland dysfunction. Ear Nose Throat J 2000; 79:460-468.
15. Helman J., Turner RJ, Fox PC, Baum BJ. 99mTc-pertechnetate uptake in parotid acinar cells by the Na+/K+/Clco-transport system. J Clin Invest 1987; 79:1310-1313.
16. Nakada K., Ishibashi T., Takei T., et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med 2005; 46:261-266.
17. Albrecht HH, Creutzig H. Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy [author's translation] [in German]. Rofo 1976; 125:546-551.
18. Chow S. Side effects of high-dose radioactive iodine for ablation or treatment of differentiated thyroid carcinoma. J HK Coll Radiol 2005; 8:127-135.